FDA greenlights Eli Lilly COVID-19 combo therapy

FDA greenlights Eli Lilly COVID-19 combo therapy

The Food and Drug Administration (FDA) has issued emergency approval to an antibody drug combo treatment from Eli Lilly for high-risk patients recently diagnosed with coronavirus disease.